News & Events
Screening Pause
Patients have been screened for the final randomisation slots in the AuToDeCRA-2 study. As a result, screening of patients is currently on hold while their eligibility is being confirmed.
Last modified: Wed, 26 Mar 2025 16:59:12 GMT
AuToDeCRA-2 on the BBC
Professor Isaacs and his team welcomed the BBC to Newcastle Hospital's Clinical Research Facility to talk about the work being done in the AuToDeCRA-2 study.
Last modified: Wed, 26 Mar 2025 17:04:19 GMT
Study recruitment total
Recruitment into the AuToDeCRA-2 study continues at a good pace. We have currently randomised 20 participants into the study.
Last modified: Wed, 26 Mar 2025 16:53:27 GMT
AuToDeCRA-2 study open to recruitment
The Newcastle team received the ok to start recruitment into the AuToDeCRA-2 study.
Last modified: Mon, 04 Mar 2024 15:49:29 GMT
Successful delivery of TolDC
Our first trial participant has successfully received our TolDC product.
Last modified: Wed, 24 Apr 2024 15:11:59 BST
Final study visits
The first participants in the AuToDeCRA-2 are now beginning to complete their final study visits which is great. A big thank you to them all for giving up their time to support research into Rheumatoid Arthritis.
Last modified: Thu, 20 Jun 2024 10:57:31 BST
.gif)
